The proposed project results from the collaboration of three complementary research bodies, the Musculoskeletal Diseases Research Laboratory “Th. Garofalidis ” of the Medical School of EKPA, the Institute of Chemical Biology of the National Research Foundation, the  Butterfly Bone Health Society and two Greek companies of CLOUDPHARM and LIFELNB.